Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience

Journal of Hepatology, Supplement

Volumn 23, Issue 2, 1995, Pages 17-21

  Schvarcz, R ^a   Ando, Y ^a   Sonnerborg, A ^a   Weiland, O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hepatitis C virus; Interferon alfa; Interferon alfa 2b; Ribavirin

Indexed keywords

ALPHA2B INTERFERON; ENDOGENOUS COMPOUND; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; HEPATITIS C; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SWEDEN;

ADULT; AGED; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; REFERENCE VALUES; RIBAVIRIN; RNA, VIRAL; SWEDEN; TIME FACTORS;

EID: 0029589231     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)